Key result
Dexamethasone was associated with a shorter median length of hospital stay compared with a prednisolone-based regimen.
Why the study?
The study was conducted to evaluate the efficacy of dexamethasone compared with a prednisone-based regimen in pediatric patients hospitalized with mild to moderate acute asthma exacerbations.
Does dexamethasone reduce length of hospital stay in pediatric patients hospitalized with mild to moderate acute asthma exacerbations compared to a prednisolone-based regimen?
Observational
Does dexamethasone reduce length of hospital stay in pediatric patients hospitalized with mild to moderate acute asthma exacerbations compared to a prednisolone-based regimen?
Dexamethasone is associated with a significantly shorter length of hospital stay compared to a prednisolone-based regimen in pediatric patients with mild to moderate acute asthma exacerbations.
Answers are grounded in this paper and cite their sources.
May warrant considering dexamethasone in pediatric regimens; leaves open whether randomized trials will confirm benefit.
A retrospective chart review was done to evaluate the efficacy of a course of dexamethasone for pediatric patients hospitalized with a mild to moderate acute asthma exacerbation compared with a prednisone-based regimen. Patients were identified based on International Classification of Diseases (ICD-9 and ICD-10) discharge diagnosis codes for asthma and cross-referenced with pharmacy dispense reports during the study period of June 2011 to January 2016. Baseline characteristics were similar among the 2 groups. The median length of hospital stay in the dexamethasone and prednisolone groups were 1.31 and 1.75 days, respectively, with a hazard ratio of 2.5 (95% confidence interval - 2.1-3.1), P < .001. After accounting for significant confounding variables, the difference in length of stay remained significantly longer in the prednisolone group with a hazard ratio of 1.8 (95% confidence interval = 1.4-2.3), P < .001. A course of dexamethasone is associated with a significantly shorter length of stay for mild to moderate asthma exacerbations compared with a prednisone-based regimen.
No takes yet. Share an insight, caveat, or question.
Bohannon et al. (2019) conducted an observational in Mild to moderate acute asthma exacerbations. Dexamethasone vs. Prednisolone-based regimen was evaluated on Length of hospital stay (HR 1.8, 95% CI 1.4-2.3, p=<.001). Dexamethasone was associated with a shorter median length of hospital stay compared with a prednisolone-based regimen.
Synapse has enriched 10 related papers. Consider them for comparative context: